DFTX:NASDAQ
Definium Therapeutics Inc
$37.73
arrow_downward
-0.68%(-0.26) 1D
$37.40
arrow_downward
-0.88% (-0.33)bedtimeAfter hours
Closed: Sep 10, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DFTX...
Open
$37.65
High
$38.19
Low
$37.17
Mkt. cap
5.07B
Avg. vol.
2.03M
Volume
0.00
52-wk high
$49.70
52-wk low
$14.62
EPS
-$3.43
Beta
2.23
Shares outstanding
134.37M
No. of employees
106
Open
$37.65
High
$38.19
Low
$37.17
Mkt. cap
5.07B
Avg. vol.
2.03M
Volume
0.00
52-wk high
$49.70
52-wk low
$14.62
EPS
-$3.43
Beta
2.23
Shares outstanding
134.37M
No. of employees
106
News stories
From web sources and news partners
GuruFocus
·
17 hours ago
Definium Therapeutics (DFTX) Showcases Phase 3 Data Amid High Va
Yahoo Finance
·
18 hours ago
Definium Therapeutics to Present Topline Data from Phase 3 Emerge and Voyage Trials Across Major Depressive Disorder and Generalized Anxiety Disorder at Psych Congress 2026
Simply Wall Street
·
2 days ago
Does Breakthrough Therapy Status Change The Bull Case For Definium Therapeutics Stock (DFTX)?
Profile
Definium Therapeutics, Inc., formerly known as MindMed, is a New York-based biotechnology company that is currently developing clinical and therapeutic applications for psychedelic and, more broadly, psychoplastogenic drugs. Wikipedia
About Definium Therapeutics Inc
CEORobert Barrow
Employees106
Founded2010
Headquarters-
SectorPharmaceutical industry
Websitedefiniumtx.com